Paul Tudor Jones Ironwood Pharmaceuticals Inc Transaction History

Tudor Investment Corp Et Al

$15.5 Billion
Q1 2024

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 64,350 shares of IRWD stock, worth $397,039. This represents 0.0% of its overall portfolio holdings.

Number of Shares

64,350

Holding current value

$397,039

% of portfolio

0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$8.32 - $15.45 $535,392 - $994,207	64,350 New	64,350 $560,000
Q2 2022 Aug 15, 2022	SELL	$11.05 - $12.72 $1.9 Million - $2.19 Million	-172,062 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$10.61 - $12.88 $1.12 Million - $1.36 Million	105,384 Added 158.05%	172,062 $2.17 Million
Q4 2021 Feb 14, 2022	SELL	$10.86 - $13.95 $184,554 - $237,066	-16,994 Reduced 20.31%	66,678 $777,000
Q3 2021 Nov 15, 2021	BUY	$11.92 - $13.92 $997,370 - $1.16 Million	83,672 New	83,672 $1.09 Million

Q2 2021 Aug 16, 2021	SELL	$10.16 - $13.11 $410,646 - $529,879	-40,418 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$9.04 - $11.86 $260,144 - $341,295	28,777 Added 247.2%	40,418 $452,000
Q4 2020 Feb 16, 2021	BUY	$9.05 - $12.2 $105,351 - $142,020	11,641 New	11,641 $133,000
Q3 2020 Nov 16, 2020	SELL	$8.99 - $10.74 $1.33 Million - $1.59 Million	-148,488 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$9.14 - $11.97 $741,637 - $971,269	81,142 Added 120.49%	148,488 $1.53 Million
Q1 2020 May 15, 2020	BUY	$8.58 - $14.01 $577,828 - $943,517	67,346 New	67,346 $680,000
Q4 2018 Feb 14, 2019	SELL	$7.8 - $16.13 $449,420 - $929,378	-57,618 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$14.31 - $17.65 $824,513 - $1.02 Million	57,618 New	57,618 $1.06 Million

Others Institutions Holding IRWD

# of Institutions

296

Shares Held

170M

Call Options Held

27.1M

Put Options Held

2.28M

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $945M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account